Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.24% | -217.12% | 68.33% | -589.05% | -68.92% |
| Total Depreciation and Amortization | 205.88% | 86.94% | 50.47% | 9.03% | -10.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.41% | 152.72% | -81.03% | 1,654.67% | 371.10% |
| Change in Net Operating Assets | -1.76% | 27.83% | 232.60% | -1,255.96% | -178.69% |
| Cash from Operations | 17.86% | 85.12% | 137.99% | -689.95% | -767.61% |
| Capital Expenditure | -275.00% | -421.24% | -142.37% | -169.94% | 67.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -162.06% | 861.01% | -104.53% | 77.42% | 166.32% |
| Cash from Investing | -165.47% | 826.39% | -106.08% | 76.21% | 164.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -62.50% | -4.36% | 48.28% | -8.88% | -5.54% |
| Issuance of Common Stock | -92.86% | -47.02% | -76.48% | -87.09% | -11.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -300.00% | -95.47% | -84.22% | -203.66% | -27.80% |
| Foreign Exchange rate Adjustments | -185.71% | -12.58% | 441.41% | 49,244.44% | 508.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -264.84% | 461.06% | -95.23% | 74.85% | 140.77% |